KAKUYASU GROUP CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,202 JPY | +4.11% |
|
+3.09% | +25.83% |
| 2023 | Kakuyasu Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2021 | COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings | RE |
Valuation
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,243 | 12,327 | 13,773 | 12,503 | 20,851 | - | - |
| Enterprise Value (EV) 1 | 10,968 | 19,785 | 22,788 | 20,244 | 26,932 | 25,227 | 23,326 |
| P/E ratio | 13.6 x | -7.67 x | -4.77 x | 20.5 x | 11.1 x | 10.3 x | 9.33 x |
| Yield | 5.25% | 3.14% | 1.35% | 2.24% | 2.27% | 2.38% | 2.5% |
| Capitalization / Revenue | 0.07 x | 0.15 x | 0.16 x | 0.11 x | 0.16 x | 0.15 x | 0.14 x |
| EV / Revenue | 0.1 x | 0.25 x | 0.27 x | 0.18 x | 0.21 x | 0.18 x | 0.15 x |
| EV / EBITDA | 5.59 x | - | - | - | 6.79 x | 5.71 x | 4.86 x |
| EV / FCF | 14.6 x | -10.3 x | -6.78 x | - | 16.2 x | 14.8 x | 12.3 x |
| FCF Yield | 6.84% | -9.69% | -14.7% | - | 6.16% | 6.76% | 8.15% |
| Price to Book | 1.41 x | 3.84 x | 5.97 x | 4.45 x | 5 x | 3.69 x | 2.84 x |
| Nbr of stocks (in thousands) | 7,633 | 7,767 | 9,306 | 9,331 | 9,469 | - | - |
| Reference price 2 | 949.0 | 1,587 | 1,480 | 1,340 | 2,202 | 2,202 | 2,202 |
| Announcement Date | 5/13/20 | 5/12/21 | 5/12/22 | 5/15/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 108,562 | 80,226 | 85,514 | 114,960 | 131,102 | 141,599 | 151,034 |
| EBITDA 1 | 1,963 | - | - | - | 3,964 | 4,420 | 4,801 |
| EBIT 1 | 1,259 | -2,602 | -3,328 | 803 | 3,056 | 3,430 | 3,755 |
| Operating Margin | 1.16% | -3.24% | -3.89% | 0.7% | 2.33% | 2.42% | 2.49% |
| Earnings before Tax (EBT) 1 | 892 | -1,888 | -3,100 | 299 | 2,954 | 3,188 | 3,517 |
| Net income 1 | 513 | -1,601 | -2,808 | 609 | 1,871 | 2,014 | 2,222 |
| Net margin | 0.47% | -2% | -3.28% | 0.53% | 1.43% | 1.42% | 1.47% |
| EPS 2 | 69.86 | -206.9 | -310.0 | 65.36 | 198.6 | 213.8 | 236.0 |
| Free Cash Flow 1 | 750 | -1,918 | -3,361 | - | 1,658 | 1,705 | 1,901 |
| FCF margin | 0.69% | -2.39% | -3.93% | - | 1.26% | 1.2% | 1.26% |
| FCF Conversion (EBITDA) | 38.21% | - | - | - | 41.83% | 38.57% | 39.6% |
| FCF Conversion (Net income) | 146.2% | - | - | - | 88.62% | 84.66% | 85.53% |
| Dividend per Share 2 | 49.80 | 49.80 | 20.00 | 30.00 | 50.00 | 52.50 | 55.00 |
| Announcement Date | 5/13/20 | 5/12/21 | 5/12/22 | 5/15/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 38,923 | 36,906 | 27,192 | 26,541 | 53,797 | 30,911 | 31,118 | 63,679 | 34,911 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | -1,514 | -2,768 | 196 | -186 | -684 | 789 | 601 | 1,131 | 1,293 |
| Operating Margin | - | -3.89% | -7.5% | 0.72% | -0.7% | -1.27% | 2.55% | 1.93% | 1.78% | 3.7% |
| Earnings before Tax (EBT) 1 | - | -1,125 | -2,420 | 208 | -186 | -751 | 660 | 567 | 825 | 1,303 |
| Net income 1 | - | -843 | -1,898 | 137 | -150 | -780 | 578 | 332 | 437 | 811 |
| Net margin | - | -2.17% | -5.14% | 0.5% | -0.57% | -1.45% | 1.87% | 1.07% | 0.69% | 2.32% |
| EPS 2 | - | -109.2 | -215.3 | 19.18 | -16.14 | -83.73 | 62.00 | 35.47 | 46.60 | 86.21 |
| Dividend per Share | 24.90 | 24.90 | 10.00 | - | - | 10.00 | - | - | 25.00 | - |
| Announcement Date | 11/18/19 | 11/12/20 | 11/12/21 | 2/10/22 | 8/12/22 | 11/11/22 | 2/13/23 | 8/14/23 | 11/14/23 | 2/14/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | 3,725 | 7,458 | 9,015 | 7,741 | 6,081 | 4,376 | 2,475 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.898 x | - | - | - | 1.534 x | 0.99 x | 0.5155 x |
| Free Cash Flow 1 | 750 | -1,918 | -3,361 | - | 1,658 | 1,705 | 1,901 |
| ROE (net income / shareholders' equity) | 10.4% | -50% | -102% | 21.7% | 56% | 40.6% | 34.1% |
| ROA (Net income/ Total Assets) | - | -6.23% | -10.4% | 2.6% | - | - | - |
| Assets 1 | - | 25,695 | 26,905 | 23,457 | - | - | - |
| Book Value Per Share 2 | 671.0 | 413.0 | 248.0 | 301.0 | 440.0 | 597.0 | 775.0 |
| Cash Flow per Share | 165.0 | -118.0 | -229.0 | 140.0 | - | - | - |
| Capex 1 | 1,179 | 284 | 919 | 1,174 | 845 | 400 | 400 |
| Capex / Sales | 1.09% | 0.35% | 1.07% | 1.02% | 0.64% | 0.28% | 0.26% |
| Announcement Date | 5/13/20 | 5/12/21 | 5/12/22 | 5/15/23 | - | - | - |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 128M | |
| +2.88% | 6.34B | |
| -2.79% | 1.02B | |
| -2.03% | 367M | |
| +0.82% | 211M | |
| -25.88% | 159M | |
| +16.54% | 110M | |
| -13.16% | 66.53M | |
| -28.10% | 50.41M |
- Stock Market
- Equities
- 7686 Stock
- Financials Kakuyasu Group Co., Ltd.
